LOOK INSIDE
Download this complimentary Infographic today!
This Infographic provides scientists with actionable insights on cutting-edge LC/MS solutions for oligonucleotide development, helping you accelerate research timelines while meeting regulatory standards.
What you will learn about:
- End-to-end analytical LC/MS solutions for confident, compliant therapeutic oligonucleotide workflows
- Advanced chromatography techniques (HILIC and ion-pairing-free methods) for environmentally friendly alternatives
- Automated workflows that minimize analyst workload and transcription errors
- High-sensitivity detection for oligonucleotides up to 3,000 m/z with enhanced impurity classification
- Cost-effective semi-preparative purification without dedicated large-scale instrumentation
Click “LOOK INSIDE” to download the PDF now.
More Information
Facing increasing complexity in oligonucleotide therapeutics development? As the field advances, laboratories require enhanced capabilities in trace impurity detection, consistent multi-site performance, and streamlined high-throughput workflows. The development of synthetic oligonucleotides—particularly antisense oligonucleotides—involves critical analysis and purification processes complicated by increasing sequence complexity, novel chemical modifications, stringent regulatory demands, and high purity requirements. Modern end-to-end LC/MS solutions can streamline your analysis-purification pipeline, accelerate development timelines, and ensure regulatory compliance.
Sponsored by
